Market Overview

UPDATE: J.P. Morgan Raises PT on Health Care REIT on Updated Model

Related HCN
1 Data-Driven Way To Play REITs
BMO Capital's John Kim Explains Why Ventas Is A Healthcare REIT Worth Watching

In a report published Friday, J.P. Morgan reiterated its Neutral rating on Health Care REIT (NYSE: HCN), and slightly raised its price target from $63.00 to $64.00.

J.P. Morgan noted, “We are updating our model post 4Q earnings. As a result, we are lowering our 2013 FFO estimate by $0.09, to $3.78. In addition, we are lowering our 2014 FFO estimate by $0.10, to $4.00. Finally, we are increasing our 2013 YE price target by $1 to $64/share as a result of a slight increase in our payout ratio assumption.”

Health Care REIT closed on Thursday at $65.16.

Latest Ratings for HCN

Nov 2015BarclaysMaintainsOverweight
Sep 2015Mizuho SecuritiesMaintainsBuy
Sep 2015Evercore PartnersMaintainsBuy

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: J.P. MorganAnalyst Color Price Target Analyst Ratings


Related Articles (HCN)

View Comments and Join the Discussion!

Get Benzinga's Newsletters